Follow Me on Pinterest

Thursday, July 15, 2021

Cell and gene data innovation and multi-stakeholder data transfer

Hello readers. It's been awhile. I'm pleased to be working with Reuters on some events including this upcoming webinar on how to utilize RWD in cell and gene therapies with speakers from Novartis, BMS and Salesforce. Click here for more info.

The requirements of complex and delicate value chains within cell and gene therapies (CGT) is something pharma has traditionally never seen before. Leaders in CGT are innovating data sharing approaches by utilizing RWE and RWD across the value chain, and achieving multi-stakeholder alignment, to ensure commercial success.












Join C&GT delivery trailblazers BMS, Novartis and Salesforce to learn how to turn data in to true insights: that enhance the science, reduce the cost of deliver, improve commercial decision-making and elevate the patient experience.

Sign up for the webinar “Cell and gene data innovation and multi-stakeholder data transfer” here.

When you join, you will learn how to:

                 Reimagine the technology: digitally transform existing data integration models for cell and gene therapies

                 Reach for the future together: develop a multi-stakeholder strategy collaboratively, that aligns on needs and capabilities

                 Cross-capture and utilize data flow from R&D through to launch to win the marketplace with science and data

                 Prepare for and address the major barriers to success: such as infrastructure non-readiness, digitally siloed stakeholders, underdeveloped partnerships, and data illiteracy

                 Turn data in to true insights: that enhance the science, reduce the cost of deliver, improve commercial decision making and elevate the patient experience

Tune in live to the free webinar on July 29 at 11am ET/4pm BST, or sign up to receive the recording here.

Please also feel free to share with your colleagues working in C&G therapy, so they can benefit too. 

Lee

 

No comments: